Nasopharyngeal Carcinoma
Melvin L.K. Chua/LinkedIn

Melvin L.K. Chua: Collaboration on Nasopharyngeal Carcinoma Between NCC Singapore and SYSUCC

Melvin L.K. Chua, Head of the Department of Head Neck and Thoracic Cancers at the National Cancer Centre Singapore, and ASCO Breakthrough Program Committee Chair, shared a post on LinkedIn:

“Nasopharyngeal Carcinoma remains a very difficult disease to treat since it affects the young and remains endemic in this part of the world.

So glad to have an afternoon engaging the world’s experts from Sun Yat-Sen University Cancer Centre – Profs Mai Hai Qiang and Tang Ling Quan to share our Precision Radiotherapeutics Oncology Programme, National Cancer Centre Singapore, and share with him our processes at the GCL Proton Therapy Centre.

SYSUCC sees 7000 NPC cases a year! Prof Mai himself treats 700 cases a year! There is so much room for collaboration between us.

Thanks to Top Alliance Biosciences Inc for hosting the visit!”

Melvin L.K. Chua: Collaboration on Nasopharyngeal Carcinoma Between NCC Singapore and SYSUCC

More posts featuring Melvin L.K. Chua.